Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Betamethasone vs dexamethasone mouthwash for pain reduction in oral lichen planus
IRCT20220509054789N1Phase 3Completed
- Sponsor
- Tabriz University of Medical Sciences
- Start
- Jun 2022
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of betamethasone and dexamethasone in oral lichen planus (OLP) (2 arms), sponsored by Tabriz University of Medical Sciences. Primary endpoint: Pain level reduction. Started Jun 2022; status: completed.
02
Drugs
betamethasonedexamethasone
03
Conditions
oral lichen planus (OLP)
Beyond the preview
Go deeper on IRCT20220509054789N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20220509054789N1.